Search Results for keywords:"revocation"

The State Department has officially revoked the designation of Ansarallah, also known by other names, as a Foreign Terrorist Organization. This decision was made in coordination with the Attorney General and the Secretary of the Treasury. The revocation is carried out under the authority of the Immigration and Nationality Act. This change will be documented in the Federal Register.

The President of the United States has issued a memorandum detailing the order of succession for officials in the Office of Personnel Management (OPM) who can act as the Director if both the Director and Deputy Director are unable to serve. The order starts with the Chief of Staff, followed by the General Counsel, and continues through other key OPM positions. However, anyone currently serving in an acting capacity in these roles cannot automatically become the acting Director. The President also reserves the right to choose a different acting Director if needed, and this memorandum revokes a previous memorandum from December 10, 2020. The memo does not create any new legal rights for or against the government.

The U.S. Department of Commerce conducted an expedited sunset review on the countervailing duty order for aluminum wire and cable from China. They concluded that if this duty order were removed, it would likely result in the continuation or recurrence of unfair subsidies. This review did not receive adequate responses from the Chinese government or other interested parties, leading to the expedited process. The decision will maintain the duty order to prevent potential subsidies at the stated rates.

The Executive Order 14007 establishes the President's Council of Advisors on Science and Technology (PCAST) to advise the President on issues related to science, technology, and innovation. The council will consist of up to 26 members, including a mix of government officials and experts from outside the federal government. The PCAST is tasked with providing scientific and technological information to help shape public policies on various national matters, such as the economy, education, energy, and public health. The order also revokes a previous order and sets guidelines for the council's administration and termination.

The Food and Drug Administration (FDA) has announced the revocation of Emergency Use Authorizations (EUAs) for three COVID-19 tests developed by Beckman Coulter, Inc., including the Access SARS-CoV-2 IgG, IgM, and IgG II tests. This action was taken upon the request of Beckman Coulter, who also decided to stop the distribution of these tests as of January 1, 2025. The FDA concluded that revoking these authorizations is necessary to protect public health and safety. The revocation became effective on January 8, 2025, with detailed explanations provided for each decision.

The Executive Order 14174 revokes two previous orders related to COVID-19 safety measures for federal contractors and vaccination requirements for federal employees. The order clarifies that it does not change the existing authority of government agencies or affect the responsibilities of the Office of Management and Budget concerning budget and legislative proposals. It also states that the order should be implemented according to existing laws and budgets, and it does not create any new legal rights for any party.

The Drug Enforcement Administration (DEA) has revoked Rachel Jackson's DEA Certificate of Registration because she is not licensed to handle controlled substances in Maine. Jackson voluntarily surrendered her Maine physician assistant license, making her ineligible to practice or register with the DEA. Despite being alerted about the situation and the chance to request a hearing, Jackson did not respond, leading to a default determination and subsequent action to revoke her registration. The order for revocation is effective from April 21, 2025.

The Drug Enforcement Administration (DEA) decided to revoke Massoud Amini, M.D.'s DEA Certificate of Registration because he currently lacks the authority to handle controlled substances in California. The DEA issued an Order to Show Cause, notifying Dr. Amini of his right to request a hearing, which he did not do, leading to a default decision. The default means that the DEA's allegations against him are accepted as true, including that his California medical license has been revoked. Consequently, Dr. Amini's DEA registration is revoked, and his pending applications for renewal or new registration are denied.

The Drug Enforcement Administration (DEA) has decided to revoke the registration of Dr. Kevin Petersen, meaning he can no longer prescribe or handle controlled substances. This decision came after it was found that his medical license in Nevada, where he practiced, had expired and was then revoked, which automatically made him ineligible to maintain his DEA registration for handling such substances. Dr. Petersen did not contest this action by requesting a hearing, leading the DEA to proceed with its final decision. This order will officially take effect on January 29, 2025.

The Drug Enforcement Administration (DEA) has decided to revoke Jason Lee Ray's DEA Certificate of Registration because he cannot legally handle controlled substances in Wyoming. This decision follows the suspension of his Wyoming physician assistant license by the Wyoming Board of Medicine. The DEA's decision emphasizes the necessity of being authorized at the state level to dispense controlled substances to maintain a DEA registration. Any applications by Jason Lee Ray to renew or modify his registration are also denied, effective January 29, 2025.